Both Annamycin dose arms outperformed control on the primary endpoint of complete remission (CR): 43% and 36% versus 12% — ...
A recent study found that a combination of dietary fibers effectively alleviated chronic constipation, enhancing bowel ...
TTI-109 delivered TTI-101-equivalent exposure with improved tolerability and meaningful reductions in disease-relevant STAT3-driven immune cell ...
After a four-month investigation, Nature Medicine has decided to pull a viral study that linked early-day PD-1/chemo ...
Data from EULAR 2026 show that next-generation CAR T- and NK cell platforms induce powerful, drug-free clinical remissions in patients with highly refractory rheumatic diseases.
Researchers have found in a pragmatic cluster-randomized quality improvement trial that asynchronous electronic (e-) screening significantly increased both screening completion rates ...
Americans love working from home. Does it love them back? A controversial new study says remote work is taking a toll on ...
MedPage Today on MSN
Gentler Regimen for HER2+ Breast Cancer Gets Good Grades in 5-Year Report
After neoadjuvant therapy, ctDNA clearance occurred in 96% of patients ...
Some of the earliest real-money online casinos offered only a small selection of games, with InterCasino often cited as ...
New human research reveals how gut bacteria and creatine may restore brain energy and improve depression. If you have or know ...
FDA's PDUFA goal date is November 1, 2026If approved, mitapivat is positioned to become the first oral PK activator for patients with sickle cell disease CAMBRIDGE, Mass., July 07, 2026 (GLOBE NEWSWIR ...
Morning Overview on MSN
Ozempic helped adults over 65 shed more than 15% of their body weight in a new study
Adults aged 65 and older who took semaglutide 2.4 mg lost an average of 15.4% of their body weight over 68 weeks, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results